Back

Determinants and long-term outcomes of COVID-19 undervaccination: a cohort study of 6.8 million individuals in Lombardy, Italy

Corbetta, A.; Logan, K. M.; Ieva, F.; Di Angelantonio, E.

2026-05-07 epidemiology
10.64898/2026.05.06.26352509 medRxiv
Show abstract

BackgroundReceiving fewer COVID-19 vaccine doses than recommended ("undervaccination") may increase risks of death, severe COVID-19, and post-COVID condition. However, population-scale evidence from Italy remains limited. We aimed to characterise determinants of undervaccination in Lombardy and to quantify its association with mortality, severe COVID-19, and long COVID outcomes. MethodsWe conducted a population-based study including all residents of Lombardy aged [&ge;]30 years who were alive on June 1, 2022 (n=6,836,566), and followed them until Dec 31, 2024. Vaccine deficit was defined as the difference between age-specific recommended doses (three for <60 years; four for [&ge;]60 years) and doses received, and was modelled as a time-varying exposure. Outcomes were all-cause mortality, severe COVID-19 (hospitalisation or COVID-19-related death), and long COVID defined using symptom-based ICD codes recorded [&ge;]1 month after infection. Determinants of undervaccination were assessed using multivariable logistic regression. Age-stratified Cox models estimated adjusted hazard ratios (HRs). Counterfactual vaccination scenarios were simulated using fitted survival models. ResultsOn June 1, 2022, 1,668,014 individuals (24{middle dot}4%) were not up to date with recommended vaccination. Undervaccination was more frequent in younger adults, women, individuals born outside Europe, rural residents, and those with high comorbidity burden. During follow-up, 265,383 deaths, 52,121 severe COVID-19 events, and 23,780 long COVID events occurred. In adults aged [&ge;]60 years, increasing vaccine deficit was associated with progressively higher risks of mortality (HR up to 1{middle dot}63) and severe COVID-19 (HR up to 2{middle dot}16). Associations were weaker in younger adults. For long COVID, effect estimates were modest and sensitive to outcome definition. Simulated universal booster coverage in adults [&ge;]60 years was associated with substantial reductions in expected deaths and severe COVID-19 events. ConclusionAbout one in four adults in Lombardy was undervaccinated by mid-2022. An increasing vaccine deficit was associated with a higher risk of severe COVID-19 and mortality, particularly in older adults. Sustaining booster uptake in high-risk groups remains central to mitigating the COVID-19 burden.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
PLOS Medicine
98 papers in training set
Top 0.2%
10.1%
2
The Lancet Infectious Diseases
71 papers in training set
Top 0.3%
6.4%
3
Vaccine
189 papers in training set
Top 0.6%
4.8%
4
Nature Communications
4913 papers in training set
Top 33%
4.8%
5
BMC Medicine
163 papers in training set
Top 0.8%
4.8%
6
Eurosurveillance
80 papers in training set
Top 0.2%
4.8%
7
BMC Public Health
147 papers in training set
Top 1%
4.2%
8
BMJ
49 papers in training set
Top 0.2%
4.2%
9
International Journal of Epidemiology
74 papers in training set
Top 0.5%
4.0%
10
The Lancet Public Health
20 papers in training set
Top 0.1%
3.9%
50% of probability mass above
11
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.2%
2.9%
12
The Lancet Healthy Longevity
11 papers in training set
Top 0.1%
2.9%
13
JAMA Network Open
127 papers in training set
Top 1%
2.6%
14
American Journal of Epidemiology
57 papers in training set
Top 0.5%
2.4%
15
The Lancet Regional Health - Europe
32 papers in training set
Top 0.1%
2.1%
16
Open Forum Infectious Diseases
134 papers in training set
Top 1%
1.9%
17
BMC Infectious Diseases
118 papers in training set
Top 3%
1.7%
18
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.7%
19
The Lancet
16 papers in training set
Top 0.3%
1.5%
20
PLOS ONE
4510 papers in training set
Top 56%
1.5%
21
BMJ Open
554 papers in training set
Top 10%
1.5%
22
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.2%
23
The Lancet Global Health
24 papers in training set
Top 0.8%
1.2%
24
Scientific Reports
3102 papers in training set
Top 70%
0.9%
25
Nature Human Behaviour
85 papers in training set
Top 4%
0.8%
26
Science
429 papers in training set
Top 19%
0.8%
27
The Lancet Regional Health - Americas
22 papers in training set
Top 0.3%
0.7%
28
International Journal of Cancer
42 papers in training set
Top 1%
0.7%
29
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.8%
0.7%
30
Influenza and Other Respiratory Viruses
44 papers in training set
Top 0.5%
0.7%